Articles > Journals > Business and Economics journals > Wireless News articles > May 2009

Article: Bayer and Onyx to Present Data on Nexavar at the ASCO Meeting

Article from:
Wireless News
Article date:
May 31, 2009
Copyright

Wireless News
05-31-2009
Bayer and Onyx to Present Data on Nexavar at the ASCO Meeting
Type: News

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. announced that more than 65 studies evaluating the use of Nexavar (sorafenib) tablets will be presented at the 2009 American Society of Clinical Oncology (ASCO) annual meeting.

"Nexavar has a proven track record in two cancers - in the treatment of unresectable hepatocellular carcinoma (HCC), or liver cancer, and in the treatment of advanced renal cell carcinoma (RCC), or kidney cancer," said Laura Brege, executive vice president and chief operating officer at Onyx Pharmaceuticals. "We continue to explore the potential of ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Renal cell carcinomas in young patients have a ...
Health & Medicine Week;  November 8, 2004 ;     700+ words ... ... morphologic and molecular characterization of renal cell carcinoma in children and young adults finds that renal cell carcinomas in young patients have a unique ... background. "A new WHO classification of renal cell carcinoma has been introduced in 2004 ...

Article: Reports on renal cell carcinoma findings from Rhode ...
Cancer Weekly;  December 23, 2008 ;     700+ words ... ... 1, 3, 4, 7, and 8 in human renal cell carcinomas and oncocytomas and ... samples from 141 patients with renal cell carcinomas or oncocytoma (90 clear ... 22 papillary, 17 chromophobe renal cell carcinomas, and 12 oncocytomas ...

Article: Simultaneous Chromophobe renal cell carcinoma and ...
Diagnostic Pathology;  August 21, 2007 ;     700+ words ... ... Gonzlez [1] Background Chromophobe renal cell carcinoma (CHRC) is a neoplasm of the ... of better prognostic than conventional renal cell carcinoma [1]. Classical and eosinophilic ... carcinoma of collecting ducts, conventional renal cell carcinoma and sarcomatoid renal ...

Article: Studies from University of Zurich in the area of papillary ...
Gene Therapy Weekly;  February 19, 2009 ;     700+ words ... ... Switzerland, "Renal cysts and clear cell renal cell carcinoma are common clinical manifestations ... mutations are common in sporadic clear cell renal cell carcinoma, but not papillary renal cell carcinoma, we asked whether there is an ...

Article: Study results from Z.L. Zhang and colleagues in the area of ...
Cancer Weekly;  November 24, 2009 ;     700+ words ... ... larger cohort of surgical specimens of renal cell carcinoma and their correlation with the progression of human renal cell carcinoma. The protein and mRNA expression ... normal renal tubular epithelial cells, renal cell carcinoma cell lines, as well as ...

Article: New renal cell carcinoma data have been reported by ...
Energy Weekly News;  March 20, 2009 ;     700+ words ... ... candidate markers to distinguish chromophobe renal cell carcinoma from other renal tumors, including ... clinically important because chromophobe renal cell carcinoma has malignant biological potential ... immunohistochemistry in 11 chromophobe renal cell carcinomas and 17 oncocytomas ...

Article: Studies from Cornell University further understanding of ...
Cancer Weekly;  June 2, 2009 ;     700+ words ... ... notable for the chromophobe subtype of renal cell carcinoma, which can be histologically ... in the United States report (see also Renal Cell Carcinoma). "KaI1 is a metastasis ... cell, 35 papillary and 31 chromophobe renal cell carcinoma samples, 28 oncocytomas and ...

Article: A case of renal cell carcinoma metastatic to the ...
Ear, Nose and Throat Journal;  May 1, 2003 ;     700+ words ...Abstract Reported cases of renal cell carcinoma metastatic to the nose or to the tongue are rare. No case of renal cell carcinoma metastatic to both sites ... months of the diagnosis. Introduction Renal cell carcinoma is the third most common ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives